Keytruda, Merck's flagship oncology drug, drives significant revenue growth, with a solid market position and patent protection ensuring continued growth. Merck is the second largest player in the ...

Merck is a top performer in the healthcare sector, with steady growth, high profitability metrics, and a robust pipeline of potential drugs. Despite a recent decrease in revenue due to reduced demand ...